Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bymaster

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 1978
Fluoxetine, a selective serotonin uptake inhibitorL Lemberger, H Rowe, R Carmichael, et al.
Brain Research Bulletin|September 1, 1979
MIF-I and postsynaptic receptor sites for dopamineR M Kostrzewa, J C Hardin, R L Snell, et al.
The British Journal of Psychiatry. Supplement|April 22, 1999
Olanzapine: a basic science updateF Bymaster, K W Perry, D L Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout miceJ Gomeza, L Zhang, E Kostenis, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's diseaseJ S Kennedy, A Zagar, F Bymaster, et al.
Biochemical and Biophysical Research Communications|March 26, 1998
Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cellsN DeLapp, S Wu, R Belagaje, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|April 1, 1978
Fluoxetine, a selective serotonin uptake inhibitorL Lemberger, H Rowe, R Carmichael, et al.
Brain Research Bulletin|September 1, 1979
MIF-I and postsynaptic receptor sites for dopamineR M Kostrzewa, J C Hardin, R L Snell, et al.
The British Journal of Psychiatry. Supplement|April 22, 1999
Olanzapine: a basic science updateF Bymaster, K W Perry, D L Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout miceJ Gomeza, L Zhang, E Kostenis, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's diseaseJ S Kennedy, A Zagar, F Bymaster, et al.
Biochemical and Biophysical Research Communications|March 26, 1998
Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cellsN DeLapp, S Wu, R Belagaje, et al.
Pageof 1